EFFICACY AND SAFETY OF NEMTABRUTINIB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF COHORT G OF THE PHASE 2 BELLWAVE-003 STUDY

EHA Library, Wojciech Jurczak, 4160961

SPANISH IMCD REGISTRY EPIDEMIOLOGY OF IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN SPAIN (ARCANA) - PREVALENCE COHORT

EHA Library, Jose Tomás Navarro Ferrando, 4160965

RISK STRATIFICATION IN ASYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA - VALIDATION AND COMPARISON OF THE DFCI AND SPANISH MODELS

EHA Library, Theresia Akhlaghi, 4160970

A PHASE 1 STUDY OF BI-1206, A MONOCLONAL ANTIBODY TO CD32B (FCγRIIB), IN COMBINATION WITH RITUXIMAB AFTER A BI-1206 SAFETY RUN-IN PHASE IN SUBJECTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Zengjun Li, 4160971

ASSESSING SECONDARY IMMUNODEFICIENCY IN A COHORT OF PATIENTS WITH WALDENSTRÖM MACROGLOBULINAEMIA

EHA Library, Nicole Japzon, 4160974

ULTRA-LOW DOSE RADIOTHERAPY COMBINED WITH ORELABRUTINIB IMPROVES THE COMPLETE RESPONSE RATE OF TREATMENT FOR LOCALIZED OCULAR ADNEXAL EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA

EHA Library, Shaoxin Yang, 4160975

CAR T-CELL VS BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Hao Yao, 4160978

EFFICACY AND SAFETY OF ORELABRUTINIB IN COMBINATION WITH OBINUTUZUMAB AND LENALIDOMIDE IN PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA: PRELIMINARY RESULTS FROM A PROSPECTIVE, SINGLE-ARM, MULTICENTER, PHASE II STUDY

EHA Library, Wei Wang, 4160979

NATIONWIDE SURVEY OF THE JOURNEY OF PATIENTS LIVING WITH FOLLICULAR LYMPHOMA IN CHINA: REAL-WORLD INSIGHTS AND ANALYSIS

EHA Library, WeiLi Zhao, 4160980

LENALIDOMIDE AND OBINUTUZUMAB FOR TREATMENT OF CHEMORESISTANT RELAPSED FOLLICULAR LYMPHOMA: A SINGLE-CENTER STUDY

EHA Library, Maria Sannikova, 4160981

BASELINE INFLAMMATION PREDICTS RESPONSE TO CD3XCD20 BISPECIFIC T CELL ENGAGERS IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA

EHA Library, Giulia Magno, 4160984

INITIAL RESULTS FROM LOTIS-7: A PHASE 1B STUDY OF LONCASTUXIMAB TESIRINE PLUS GLOFITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Juan Pablo Alderuccio, 4160985

MULTICENTER REAL-WORLD OUTCOMES OF FRONTLINE POLA-R-CHP IN TREATMENT NAÏVE DLBCL

EHA Library, Swetha Thiruvengadam, 4160988

RELAPSE PATTERNS AND CLINICAL CHARACTERISTICS OF PATIENTS WITH PRIMARY TESTICULAR LYMPHOMA (PTL) OR TESTICULAR INVOLVEMENT IN THE FLYER, UNFOLDER AND RICOVER-60 TRIALS IN AGGRESSIVE B-CELL-LYMPHOMA

EHA Library, Igor Age Kos, 4160989

OPTIMIZING POST-CHIMERIC ANTIGEN RECEPTOR T CELL MONITORING: EVIDENCE ACROSS LISOCABTAGENE MARALEUCEL PIVOTAL CLINICAL TRIALS AND REAL-WORLD EXPERIENCE

EHA Library, Matthew Lunning, 4160990

FINAL ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB (ZANU) PLUS LENALIDOMIDE (LEN) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Huilai Zhang, 4160992

TIRABRUTINIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE II PROSPECT STUDY

EHA Library, Christian Grommes, 4160993

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CAR-T CELL THERAPY SIGNIFICANTLY IMPROVES PROGRESSION-FREE SURVIVAL IN RELAPSED REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Rui Liu, 4160994

OUTCOMES WITH CAR-T IN PATIENTS WITH T CELL HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA, UK EXPERIENCE

EHA Library, Dima El-Sharkawi, 4160996

PLASMABLASTIC LYMPHOMA: POPULATION-BASED TREATMENT STRATEGIES AND OUTCOME

EHA Library, Diana Al-Sarayfi, 4160997

18F-FDG PET RADIOMICS SCORE CONSTRUCTION BY AUTOMATIC MACHINE LEARNING FOR TREATMENT RESPONSE PREDICTION IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER STUDY

EHA Library, Jingyan Xu, 4160999

REDEFINING MAINTENANCE STRATEGIES IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: A DUAL-CENTER RETROSPECTIVE COMPARISON OF BTK INHIBITORS AND LENALIDOMIDE

EHA Library, Xiaoli Chang, 4161002

A PHASE I/II STUDY OF ORELABRUTINIB COMBINED WITH ANTI-PROGRAMMED CELL DEATH PROTEIN-1 ANTIBODY AND FOTEMUSTINE FOR PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

EHA Library, Wanyue Zhao, 4161003

GOLCADOMIDE (GOLCA), A CEREBLON E3 LIGASE MODULATOR (CELMOD™) AGENT, ± RITUXIMAB (R) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): UPDATED PHASE 1/2 STUDY RESULTS

EHA Library, Emmanuel Bachy, 4161005

TREATMENT OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH HIGH CARDIOVASCULAR RISK AND TREATED WITH NON-ANTHRACYCLINE-CONTAINING REGIMENS

EHA Library, Justin Darrah, 4161006

ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPECTIVE MULTICENTER PHASE II STUDY

EHA Library, Shujuan Wen, 4161007

AZACYTIDINE COMBINED WITH CHOP REGIMEN FOR THE TREATMENT OF NEWLY DIAGNOSED ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Wenjuan Yu, 4161008

FOUR CYCLES OF R-CHOP SHOW THE SAME EFFECTIVITY AS SIX CYCLES IN REAL-WORLD DLBCL PATIENTS WITH LOCALIZED, NON-BULKY DISEASE INDEPENDENTLY OF OTHER UNFAVOURABLE RISK FACTORS

EHA Library, Diana Malarikova, 4161010

ORELABRUTINIB, RITUXIMAB, AND THIOTEPA (ORT) IN COMBINATION WITH ORWITHOUT HIGH-DOSE METHOTREXATE IN UNTREATED PRIMARY CENTRAL NERVOUSSYSTEM LYMPHOMA

EHA Library, Wenjuan Yu, 4161013

PATIENT PREFERENCES FOR ATTRIBUTES OF BISPECIFIC ANTIBODIES INDICATED FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES

EHA Library, Erin Mulvey, 4161018

BRUTON'S TYROSINE KINASE (BTK) INHIBITORS FOR THE FIRST-LINE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): A RETROSPECTIVE SINGLE CENTER STUDY

EHA Library, Fang shu Guan, 4161019

PREEMPTIVE TMP-SMX/N-ACETYLCYSTEINE PROPHYLAXIS MITIGATES THE INCIDENCE OF INTERSTITIAL PNEUMONIA IN DLBCL IMMUNOCHEMOTHERAPY: A DUAL-CENTER COHORT STUDY ON RISK STRATIFICATION AND CLINICAL OUTCOMES

EHA Library, wenwen wang, 4161020

RAPID RAMP-UP OF BI-SPECIFIC ANTIBODIES IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Yucai Wang, 4161023

NOVEL SMALL MOLECULAR TARGET AGENTS WITH HD-MTX-BASED REGIMENS IMPROVED REMISSION RATES WITHOUT PROLONGING PFS IN NEWLY DIAGNOSED PCNSL

EHA Library, Huiying Zhu, 4161024

EXPLORING DISPARITIES IN SURVIVAL OUTCOMES OF PRIMARY CARDIAC DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A SEER DATABASE ANALYSIS

EHA Library, Jeyapradeeban Arunachalam, 4161025

COMPARATIVE EFFICACY OF THERAPEUTIC APPROACHES IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Abat Khan, 4161026

COMPARISON OF 18F-FDG PET/CT AND BONE MARROW BIOPSY IN DETECTION OF BONE MARROW INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Fahong Yan, 4161033

GLOFITAMAB COMBINED WITH SALVAGE THERAPY FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A REAL-WORLD PROSPECTIVE OBSERVATIONAL STUDY IN CHINESE PATIENTS

EHA Library, Haiwen Huang, 4161037

PEGFILGRASTIM VS. FILGRASTIM FOR FEBRILE NEUTROPENIA PREVENTION IN THE FIRST CYCLE OF POLATUZUMAB VEDOTIN-R-CHP (POLA-R-CHP): A NATIONWIDE COHORT STUDY IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Nobuyuki Kabasawa, 4161039

EXPOSURE TO PM10 ELEVATES THE RISK OF DIFFUSE LARGE B-CELL LYMPHOMA: A PROSPECTIVE STUDY IN THE UK BIOBANK COHORT

EHA Library, Yiyin Chen, 4161040

COMBINATION OF LIPOSOMAL MITOXANTRONE WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE (CMOP) IN TREATMENT-NAÏVE PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE IB STUDY

EHA Library, Huiqiang Huang, 4161045

CHIDAMIDE IN COMBINATION WITH AZACITIDINE, MITOXANTRONE LIPOSOMES, AND PREDNISONE (CAMP REGIMEN) FOR TREATMENT-NAÏVE TFH-DERIVED PERIPHERAL T-CELL LYMPHOMA

EHA Library, Huimin Liu, 4161049

SUBDIAPHRAGMATIC DISEASE AND HIGH FIL SCORE PERFORM BETTER THAN IPI IN IDENTIFYING A SUBGROUP OF PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA WITH A LESS FAVOURABLE PROGNOSIS

EHA Library, Simone Maifredi, 4161052

EPCORITAMAB WITH GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (EPCO-GDP) IN RELAPSED REFRACTORY LARGE B-CELL LYMPHOMA- AN INTERIM ANALYSIS OF PHASE II MULTICENTER INVESTIGATED-INITIATED TRIAL

EHA Library, Dipenkumar Modi, 4161053

LONG-TERM FOLLOW-UP REVEALS CURATIVE POTETIAL AND FAVORABLE SAFETY OF CD19/22 CAR-T THERAPY, ALONE OR IN COMBINATION WITH ASCT, IN TP53-ALTERED RELAPSED/REFRACTORY B-NHL

EHA Library, Juan Peng, 4161056

DLBCL-ASSOCIATED PIM1 MUTATION DRIVES ANXA2 RELOCATION ON THE MEMBRANE AND PROMOTES LYMPHOMAGENESIS

EHA Library, Yaxiao Lu, 4161057

NR4A1 LOSS PROMOTES AN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT AND ENHANCES LYMPHOMA PROGRESSION

EHA Library, Katrin Pansy, 4161059

DC-SIGN LOCALIZATION AND CONTRIBUTION TO TUMOUR CELL FUNCTION IN FOLLICULAR LYMPHOMA

EHA Library, Giorgia Chiodin, 4161060

MATCHING-ADJUSTED INDIRECT COMPARISON OF EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE VS TAFASITAMAB WITH RITUXIMAB + LENALIDOMIDE IN SECOND-LINE+ FOLLICULAR LYMPHOMA

EHA Library, Julie Vose, 4160960

CHIDAMIDE IN COMBINATION WITH ANTI-CD20 MONOCLONAL ANTIBODY PLUS CHOP FOR TREATING NEWLY DIAGNOSED B-CELL NON-HODGKIN LYMPHOMA WITH EPIGENETIC MUTATIONS: PRELIMINARY ANALYSIS FROM A PHASE II STUDY

EHA Library, Hongmei Jing, 4160962

ZANUBRUTINIB COMBINED WITH BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA: A PROSPECTIVE OPEN-LABEL SINGLE-ARM PHASE II CLINICAL STUDY

EHA Library, He Huang, 4160963

LONG-TERM OUTCOMES IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS WHO DISCONTINUE BRUTON'S TYROSINE KINASE INHIBITOR (BTKI) THERAPY

EHA Library, Karan Chohan, 4160964

PHASE II INVESTIGATOR-INITIATED TRIAL OF EPCORITAMAB-LENALIDOMIDE IN TREATMENT NAÏVE FOLLICULAR LYMPHOMA

EHA Library, Swetha Thiruvengadam, 4160966

RITUXIMAB, LENALIDOMIDE AND ZANUBRUTINIB CHEMO-FREE REGIMEN FOLLOWED BY IMMUNOCHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA: AN INVESTIGATOR INITIATED, SINGLE ARM, PHASE 2 TRIAL

EHA Library, Xi Chen, 4160967

THE EXPRESSION INTENSITY OF KI-67 WAS ASSOCIATED WITH PROGNISIS IN FOLLICULAR LYMPHOMA GRADE 3A

EHA Library, Wenjuan Yu, 4160968

BALANCING SAFETY AND EFFICACY OF BENDAMUSTINE PLUS ANTI CD20 REGIMENS IN ELDERLY PATIENTS (>70 Y) WITH FOLLICULAR LYMPHOMA: A TERTIARY ACADEMIC CENTER EXPERIENCE

EHA Library, Mattia D'Antiga, 4160969

PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH EPCORITAMAB WITHIN THE ENTIRE STUDY COHORT AND IN PATIENTS WITH SYMPTOMS AT BASELINE

EHA Library, P. Connor Johnson, 4160972

DETECTION OF RECURRENT GENOMIC ALTERATIONS AND MINIMAL RESIDUAL DISEASE WITH CELL-FREE DNA AND BONE MARROW IN WALDENSTRÖM'S MACROGLOBULINEMIA.

EHA Library, Signy Chow, 4160973

THE RATIONALITY, EFFICACY AND SAFETY OF ORELABRUTINIB PLUS OBINUTUZUMAB (O2) IN SYSTEMIC TREATMENT-NAÏVE MARGINAL ZONE LYMPHOMA: A PROSPECTIVE COHORT STUDY

EHA Library, Jiadai Xu, 4160976

OBINUTUZUMAB COMBINED WITH BENDAMUSTINE IN THE TREATMENT OF MATURE B-CELL LYMPHOMA: AN OPEN-LABEL, MULTICENTER STUDY

EHA Library, Shuhua Yi, 4160977

GLOFITAMAB PLUS GEMCITABINE AND OXALIPLATIN (GLOFIT-GEMOX) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): 2-YEAR FOLLOW-UP OF STARGLO

EHA Library, Gareth Gregory, 4160983

CIRCULATING TUMOUR DNA-DIRECTED INTERVENTION WITH EPCORITAMAB ALONE OR IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IS FEASIBLE IN THE EARLY POST-CAR-T POPULATION AT HIGH RISK OF RELAPSE: PRELIMINARY DATA FROM EPLCART

EHA Library, Mark Dowling, 4160986

FRONTLINE BRENTUXIMAB VEDOTIN AND CHP IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH

EHA Library, Swaminathan Iyer, 4160987

ORELABRUTINIB, RITUXIMAB COMBINED WITH HIGH-DOSE METHOTREXATE AS INDUCTION THERAPY IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Xibin Xiao, 4160991

RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A MULTINATIONAL REAL-LIFE STUDY

EHA Library, Theodoros Vassilakopoulos, 4160995

ZILOVERTAMAB VEDOTIN PLUS STANDARD OF CARE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM THE PHASE 2/3 WAVELINE-003 STUDY

EHA Library, Antonio Pinto, 4160998

A CAMPUS ALL RETROSPECTIVE MULTICENTER STUDY ON THE OUTCOME OF ADULT LYMPHOBLASTIC LYMPHOMA PATIENTS TREATED IN THE REAL-LIFE ACCORDING TO THE GIMEMA LAL1913 PROTOCOL

EHA Library, Mario Delia, 4161000

SAFETY AND EFFICACY OF AZD0486, A CD19XCD3 T-CELL ENGAGER, IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dok Hyun Yoon, 4161001

THREE-YEAR REAL-WORLD MORTALITY ANALYSIS OF CAR-T THERAPIES: TISA-CEL, AXI-CEL, AND LISO-CEL

EHA Library, Vladimir Otasevic, 4161004

BRENTUXIMAB VEDOTIN (BV) IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS (R/R PTCL): A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Ivan Dlouhy, 4161009

MAINTENANCE THERAPY OF GOLIDOCITINIB, A JAK1 SELECTIVE INHIBITOR, IN PATIENTS WITH PERIPHERAL T CELL LYMPHOMAS AFTER FIRST-LINE SYSTEMIC THERAPY: UPDATES OF THE PHASE 2 STUDY (JACKPOT26)

EHA Library, Jie Jin, 4161011

INFECTIOUS COMPLICATIONS OF AGENTS USED IN T-CELL LYMPHOMAS: A DISPROPORTIONALITY ANALYSIS USING THE FAERS DATABASE

EHA Library, Toshali Pandey, 4161012

TREATMENT AND OUTCOMES OF NEWLY DIAGNOSED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PORTUGUESE POPULATION-BASED STUDY

EHA Library, Maria Carolina AFONSO, 4161014

LINPERLISIB COMBINED WITH CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION AND LINPERLISIB MAINTENANCE IN PATIENTS WITH NEWLY DIAGNOSED NODAL T FOLLICULAR HELPER CELL LYMPHOMA: INTERIM ANALYSIS OF A PHASE II TRIAL

EHA Library, Weiping Liu, 4161015

MATCH-ADJUSTED COMPARATIVE ANALYSIS OF THE EFFICACY OF EPCORITAMAB + R-MINICHOP VS R-MINICHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Justin Darrah, 4161016

ORELABRUTINIB ADDITION TO R-CHOP-LIKE REGIMEN ADAPTED TO RESPONSE IN TREATMENT-NAÏVE NON-GCB DLBCL: UPDATE RESULTS OF ORIENT STUDY

EHA Library, Chang-Ju Qu, 4161017

EFFECTIVENESS AND GENE PROFILE OF FRONT-LINE POLA-BASED REGIMEN FOR DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A REAL-WORLD, SINGLE-CENTER STUDY INCLUDING DATA ON TP53 MUTATED PATIENTS

EHA Library, Jia Liu, 4161021

PERSISTING THROMBOCYTOPENIA AFTER CD19-DIRECTED CAR-T CELL THERAPY IS A PREDICTOR OF WORSE SURVIVAL IN RELAPSED / REFRACTORY LBCL PATIENTS

EHA Library, Akhil Behringer, 4161022

PROGNOSTIC VALUE OF EZH2-POSITIVE TUMOR CELLS AND CD8 T-LYMPHOCYTES OF THE MICROENVIRONMENT IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Vitaliy Rosin, 4161027

LATEST UPDATE RESULTS OF P-GEMD REGIMEN IN NEWLY DIAGNOSED EARLY NON-UPPER AERO-DIGESTIVE TRACT OR ADVANCED STAGE EXTRANODAL NK/T CELL LYMPHOMA

EHA Library, Jinhua Liang, 4161028

DIAGNOSTIC DISCREPANCY OF CT AND FDG PET-CT AT INTERIM STAGING AND END OF TREATMENT IN FRAIL PATIENTS WITH LBCL TREATED WITH R-MINICHOP+/-ACALABRUTINIB

EHA Library, Igor Age Kos, 4161029

INTERIM ANALYSIS OF POMALIDOMIDE PLUS RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (PR-ICE) IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A PHASE I/II STUDY (PRIDE STUDY)

EHA Library, WeiLi Zhao, 4161030

UPDATED SAFETY RUN-IN RESULTS FROM LOTIS-5: A PHASE 3, RANDOMIZED TRIAL OF LONCASTUXIMAB TESIRINE WITH RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL/HGBL

EHA Library, Carmelo Carlo-Stella, 4161031

THE EFFECT OF KIR HAPLOTYPE ON CLINICAL COURSE IN PATIENTS WITH METHOTREXATE-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Norina Tanaka, 4161032

A COMBINED EASIX-IPI (E-IPI) SCORE IMPROVES THE PROGNOSTIC STRATIFICATION OF NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Jing Yuan Tan, 4161034

CLADRIBINE AND VENETOCLAX FOR TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY T-CELL PROLYMPHOCYTIC LEUKEMIA

EHA Library, Caitlin Rausch, 4161035

PREDICTIVE FACTORS OF FAILURE OF CAR T CELLS AS A SECOND-LINE THERAPY FOR REFRACTORY OR EARLY-RELAPSING LARGE B-CELL LYMPHOMA

EHA Library, Agathe Vély, 4161036

CLINICAL FEATURES AND OUTCOMES OF EXTRANODAL NK/T-CELL LYMPHOMA INCLUDING EXTRANASAL DISEASE

EHA Library, Yuka Morita, 4161038

EFFECTIVENESS AND SAFETY OF POLA-R-CHP REGIMEN IN PREVIOUSLY UNTREATED LOW-RISK DLBCL: A NATIONWIDE MULTICENTER RETROSPECTIVE STUDY OF IPI 0-1 PATIENTS IN CHINA

EHA Library, Yuhong Ren, 4161041

MATCH-ADJUSTED COMPARATIVE ANALYSIS OF EPCORITAMAB + R-DHAX/C OR R-ICE VS R-DHAX/C OR R-ICE IN 2L+ TRANSPLANT-ELIGIBLE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Justin Darrah, 4161042

ORELABRUTINIB PLUS BENDAMUSTINE-RITUXIMAB (OBR) VERSUS BENDAMUSTINE-RITUXIMAB (BR) IN TRANSPLANT-INELIGIBLE, INTERMEDIATE- TO HIGH-RISK MANTLE CELL LYMPHOMA (MCL)

EHA Library, Li Wang, 4161043

MAINTAINING R-CHOP INTENSITY IS ASSOCIATED WITH PROLONGED DURATION OF COMPLETE REMISSION IN LARGE B-CELL LYMPHOMA: A MULTI-CENTER REAL-LIFE DATA OF 953 PATIENTS FROM TÜRKIYE

EHA Library, Umut Yılmaz, 4161044

ORELABRUTINIB COMBINED WITH ICE REGIMEN WITH OR WITHOUT RITUXIMAB (O-ICE±R) FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA WITH EXTRANODAL INVOLVEMENT

EHA Library, Xianggui Yuan, 4161046

EFFICACY OF BTK INHIBITOR, RITUXIMAB, AND LENALIDOMIDE COMBINATION THERAPY IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS IN CHINA

EHA Library, Yunfei Lv, 4161047

CD47 IMMUNOEXPRESSION DOES NOT CORRELATE WITH RESPONSE TO IMMUNOCHEMOTHERAPY AND OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA

EHA Library, Ilija Bukurecki, 4161048

CLINICAL OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HEPATOSPLENIC T-CELL LYMPHOMA

EHA Library, Zhuoxin Zhang, 4161050

ASSOCIATION OF DYNAMIC CHANGES IN METABOLIC SYNDROME COMPONENTS WITH CLINICAL OUTCOMES IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dewan Zhao, 4161051

ADVANCING PROGNOSIS: A ROBUST PREDICTIVE MODEL FOR LONG-TERM SURVIVAL IN R/R LBCL PATIENTS TREATED WITH CD19 CAR-T THERAPY

EHA Library, Hu Qian, 4161054

DISSECTING THE HELLS GENE SIGNATURE IN ANAPLASTIC LARGE CELL LYMPHOMA: IMPLICATIONS FOR DRUG REPURPOSING AND COMBINATION THERAPY

EHA Library, Valentina Fragliasso, 4161055

NON-VIRAL CD79B-TARGETED CARCIK CELLS ARMORED WITH IL-18: GOING BEYOND CD19 TARGETING

EHA Library, Beatrice Landoni, 4161058